Navigating The Prostate Cancer Frontier: A Bibliometric and Altmetric Analysis of [225Ac] Ac-PSMA Therapy
The main aim of this study was to evaluate the current state of bibliometric and altmetric
research output of [225 Ac] Ac-Prostate specific membrane antigen (PSMA) and its …
research output of [225 Ac] Ac-Prostate specific membrane antigen (PSMA) and its …
[HTML][HTML] From Despair to Hope: First Arabic Experience of 177Lu-PSMA and 161Tb-PSMA Therapy for Metastatic Castration-Resistant Prostate Cancer
A Al-Ibraheem, AS Abdlkadir, DA Sweedat, S Maus… - Cancers, 2024 - mdpi.com
Simple Summary The recent approval of [177Lu] Lu-prostate-specific membrane antigen
(PSMA) for managing metastatic castration-resistant prostate cancer (mCRPC) has …
(PSMA) for managing metastatic castration-resistant prostate cancer (mCRPC) has …
[HTML][HTML] Incidental Intense Fibroblast Activation Protein Inhibitor (FAPI) Uptake in Bilateral Gluteal Myositis Ossificans: A Case Report
R Al-Rashdan, S Ruzzeh, N Al-Hajaj, U Al-Rasheed… - Cureus, 2024 - ncbi.nlm.nih.gov
Positron emission tomography/computed tomography (PET/CT) using 18F-
fluorodeoxyglucose ([18F]-FDG) is a widely adopted imaging modality for detecting …
fluorodeoxyglucose ([18F]-FDG) is a widely adopted imaging modality for detecting …
[HTML][HTML] Fibroblast Activation Protein Inhibitor Theranostics: A Huge Opportunity with its Fair Share of Oncological Pitfalls
A Al-Ibraheem - World Journal of Nuclear Medicine, 2024 - thieme-connect.com
Positron emission tomography (PET) imaging, utilizing fluorodeoxyglucose (FDG) as a
primary radiotracer, has significantly advanced the field of nuclear oncology. However, its …
primary radiotracer, has significantly advanced the field of nuclear oncology. However, its …